Tripar Multivision Plus Tbk PT
IDX:RAAM
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
300
625
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Tripar Multivision Plus Tbk PT
Current Assets | 516.4B |
Cash & Short-Term Investments | 177.7B |
Receivables | 220.8B |
Other Current Assets | 117.9B |
Non-Current Assets | 1.4T |
Long-Term Investments | 1T |
PP&E | 132.9B |
Intangibles | 156.3m |
Other Non-Current Assets | 248.5B |
Current Liabilities | 466.7B |
Accounts Payable | 17B |
Accrued Liabilities | 1.7B |
Short-Term Debt | 262.8B |
Other Current Liabilities | 185.2B |
Non-Current Liabilities | 71.7B |
Long-Term Debt | 63B |
Other Non-Current Liabilities | 8.7B |
Balance Sheet
Tripar Multivision Plus Tbk PT
Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|
Assets | ||||||
Cash & Cash Equivalents |
19 515
|
15 188
|
8 778
|
18 425
|
114 411
|
|
Cash |
19 515
|
15 188
|
8 778
|
18 425
|
89 411
|
|
Cash Equivalents |
0
|
0
|
0
|
0
|
25 000
|
|
Short-Term Investments |
2 000
|
0
|
0
|
0
|
0
|
|
Total Receivables |
204 655
|
173 681
|
158 869
|
201 021
|
392 724
|
|
Accounts Receivables |
181 718
|
146 211
|
134 316
|
197 275
|
376 182
|
|
Other Receivables |
22 937
|
27 469
|
24 553
|
3 747
|
16 542
|
|
Inventory |
2 107
|
2 512
|
2 743
|
1 837
|
1 153
|
|
Other Current Assets |
89 625
|
69 346
|
91 041
|
56 597
|
43 099
|
|
Total Current Assets |
317 902
|
260 727
|
261 430
|
277 880
|
551 387
|
|
PP&E Net |
135 900
|
140 051
|
127 005
|
119 939
|
126 150
|
|
PP&E Gross |
135 900
|
140 051
|
127 005
|
119 939
|
126 150
|
|
Accumulated Depreciation |
93 287
|
105 485
|
118 583
|
132 188
|
141 586
|
|
Intangible Assets |
286
|
258
|
231
|
204
|
177
|
|
Long-Term Investments |
592 632
|
564 211
|
594 247
|
512 219
|
527 000
|
|
Other Long-Term Assets |
109 402
|
157 046
|
177 224
|
194 523
|
223 922
|
|
Total Assets |
1 156 121
N/A
|
1 122 293
-3%
|
1 160 137
+3%
|
1 104 766
-5%
|
1 428 636
+29%
|
|
Liabilities | ||||||
Accounts Payable |
41 830
|
28 966
|
30 076
|
15 886
|
26 557
|
|
Accrued Liabilities |
1 725
|
1 379
|
4 062
|
12 900
|
1 437
|
|
Short-Term Debt |
153 799
|
140 576
|
155 398
|
68 070
|
103 480
|
|
Current Portion of Long-Term Debt |
6 933
|
3 335
|
2 122
|
23 043
|
3 014
|
|
Other Current Liabilities |
48 883
|
46 292
|
39 849
|
12 451
|
41 120
|
|
Total Current Liabilities |
253 170
|
220 548
|
231 506
|
132 350
|
175 608
|
|
Long-Term Debt |
44 546
|
63 056
|
65 049
|
53 871
|
19 432
|
|
Deferred Income Tax |
4 374
|
0
|
0
|
0
|
0
|
|
Minority Interest |
1 675
|
1 345
|
2 786
|
116
|
113
|
|
Other Liabilities |
27 678
|
48 126
|
44 244
|
5 737
|
7 205
|
|
Total Liabilities |
328 094
N/A
|
333 074
+2%
|
343 586
+3%
|
192 075
-44%
|
202 358
+5%
|
|
Equity | ||||||
Common Stock |
315 900
|
315 900
|
315 900
|
315 900
|
371 652
|
|
Retained Earnings |
513 157
|
473 747
|
499 826
|
573 601
|
676 585
|
|
Additional Paid In Capital |
0
|
0
|
0
|
18 685
|
174 676
|
|
Other Equity |
1 030
|
428
|
825
|
4 505
|
3 364
|
|
Total Equity |
828 027
N/A
|
789 220
-5%
|
816 551
+3%
|
912 691
+12%
|
1 226 277
+34%
|
|
Total Liabilities & Equity |
1 156 121
N/A
|
1 122 293
-3%
|
1 160 137
+3%
|
1 104 766
-5%
|
1 428 636
+29%
|
|
Shares Outstanding | ||||||
Common Shares Outstanding |
6 194
|
6 194
|
6 194
|
6 194
|
6 194
|